Aminolevulinic acid hydrochloride in combination with photodynamic therapy has been approved for the treatment of BCC.

Patients with HS who present to the emergency department vs ambulatory care for pain are significantly more likely to be ...

The FDA has accepted the Biologics License Application for SkinTE, granting it Priority Review for the treatment of Wagner grade 1 diabetic foot ulcers.

Research is needed on the real-world performance of clinical AI tools in dermatology, yet many patients use available consumer-facing tools.

Results of a systematic review and meta-analysis confirm the efficacy and safety of oral JAK inhibitors for the treatment of alopecia areata.

A coroner has confirmed that measles killed 1 infant last month, but federal officials still are not counting the death in their tally.

Baseline clinical factors that predict treatment response varied by the type of therapy utilized among patients with plaque psoriasis.

Oral probiotic supplementation may be beneficial for skin hydration and barrier function, but additional research is needed.

The FDA has accepted a New Drug Application with Priority Review for zasocitinib, an investigational oral TYK2 inhibitor for plaque psoriasis.

Adults who adhere to healthy habits regarding alcohol consumption, smoking cessation, sleep, and physical activity have a lower risk for incident AD.

Low-dose micronized isotretinoin was an effective and safe therapy option for severe recalcitrant nodular acne in real-world settings.

Upadacitinib may be a safe and effective future therapy option for the management of severe alopecia areata in adults and adolescents.